| 1 |
24955549 | High-level expression, purification and study of bioactivity of fusion protein M-IL-2((88)Arg, (125)Ala) in Pichia pastoris. | 2014 Sep |
1 |
| 2 |
25451252 | Optimization protein productivity of human interleukin-2 through codon usage, gene copy number and intracellular tRNA concentration in CHO cells. | 2014 Nov 14 |
2 |
| 3 |
23484211 | Short cell-penetrating peptides: a model of interactions with gene promoter sites. | 2013 Jan |
1 |
| 4 |
17872379 | Contributions of intracellular loops 2 and 3 of the lutropin receptor in Gs coupling. | 2008 Jan |
1 |
| 5 |
17502353 | Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation. | 2007 Jul |
1 |
| 6 |
16622285 | Expression and purification of a mutant of human interleukin-2 in Pichia pastoris. | 2006 Apr |
2 |
| 7 |
15638990 | Stability of Ala 125 recombinant human interleukin-2 in solution. | 2005 Jan |
2 |
| 8 |
16108369 | [Studies on fermentation conditions and purification of mutant human interleukin-2 expressed in Pichia pastoris]. | 2005 May |
1 |
| 9 |
15004204 | HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes. | 2004 Mar 15 |
1 |
| 10 |
12350108 | Isolation and characterization of modified species of a mutated (Cys125 -Ala) recombinant human interleukin-2. | 2002 Sep 20 |
1 |
| 11 |
9144530 | Structural modifications of interleukin-2 at positions 47 and 65. | 1997 Apr 17 |
1 |
| 12 |
7636534 | Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study. | 1995 Aug |
2 |
| 13 |
8588953 | Pharmacokinetic, pharmacodynamic, and pharmacotoxic profiles of recombinant-methionyl human interleukin-2[alanine-125] (r-metHuIL-2[ala-125]) following intravenous and subcutaneous administration in rats. | 1995 Nov |
2 |
| 14 |
2009236 | Blood coagulation abnormalities during adoptive immunotherapy with interleukin-2 (r-Met Hu IL-2 [ala 125]). | 1991 Jan |
3 |
| 15 |
2208578 | Pharmacokinetics of repeated i.v. bolus administration of high doses of r-met-Hu interleukin-2 in advanced cancer patients. | 1990 |
2 |
| 16 |
2319262 | A pilot study of intralymphatic interleukin-2. II. Clinical and biological effects. | 1990 Feb |
1 |
| 17 |
2351778 | Haemodynamic effects induced by intravenous administration of high doses of r-Met Hu IL-2 [ala-125] in patients with advanced cancer. | 1990 |
2 |
| 18 |
2784163 | Systemic administration of recombinant methionyl human interleukin-2 (Ala 125) to cancer patients: clinical results. | 1989 Feb |
1 |
| 19 |
2787749 | Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. | 1989 Jun |
1 |
| 20 |
2461206 | Modifications of plasma lipids, lipoproteins and apolipoproteins in advanced cancer patients treated with recombinant interleukin-2 and autologous lymphokine-activated killer cells. | 1988 Oct |
2 |
| 21 |
2851586 | High-level expression of human BSF-2/IL-6 cDNA in Escherichia coli using a new type of expression-preparation system. | 1988 Jul |
1 |
| 22 |
3066670 | Construction, purification and biological activities of recombinant human interleukin-2 analogs. | 1988 |
2 |
| 23 |
3258574 | Stimulation of growth of Nb2 lymphoma cells by interleukin-2 in serum-free and serum-containing media. | 1988 Feb |
2 |
| 24 |
3116720 | Binding, uptake and degradation of human recombinant interleukin-2 (125 ala) in activated human T- and B-lymphocytes and in monocyte-macrophages. | 1987 May |
3 |
| 25 |
3485976 | Separation of recombinant human interleukin-2 and methionyl interleukin-2 produced in Escherichia coli. | 1986 Mar 28 |
5 |
| 26 |
3489566 | Suppression of cytotoxic T-lymphocyte activation by pyruvate and L-alanine. | 1986 May |
1 |
| 27 |
3491089 | The development of anti-interleukin-2 antibodies in patients treated with recombinant human interleukin-2 (IL-2). | 1986 Nov |
1 |